Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 151

Sort by

Sort Order Select

Journal Articles

Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow

Colin D. Godwin, MDMPhil, Yi Zhou, MD PhD, Megan Othus, PhD, Carole M. Shaw, BA, Kelda M. Gardner, PA-C, Brent L Wood, MD PhD, Roland B. Walter, MD PhD MS, Elihu H. Estey, MD

Blood (2019) 134 (Supplement_1): 2729.

https://doi.org/10.1182/blood-2019-127128

Published: 2019

Journal Articles

A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia

Carmen Fava, Paola Berchialla, PhD, Jessica Petiti, PhD, Maria Teresa Bochicchio, Barbara Izzo, PhD, Emilia Giugliano, Emanuela Ottaviani, Santa Errichiello, PhD, Giovanna Rege Cambrin, MD PhD, Claudia Venturi, Luigiana Luciano, Filomena Daraio, Daniele Calistri, Alessandro Martino, Giuseppe Saglio, MD, Giovanni Martinelli, MD, Fabrizio Pane, MD, Daniela Cilloni, MD PhD, Enrico Marco Gottardi

Blood (2019) 134 (Supplement_1): 2092.

https://doi.org/10.1182/blood-2019-125614

Published: 2019

Journal Articles

Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma

Chang Xu, Ally Studer, Xueyan Chen, MD, Eric Hoyle, David Wu, MD PhD, Zhengwei Mao, Brent L Wood, MD PhD

Blood (2019) 134 (Supplement_1): 1475.

https://doi.org/10.1182/blood-2019-131360

Published: 2019

Journal Articles

Utility of Flow Cytometry and Fluorescence in Situ Hybridization in Follow-up Monitoring of Multiple Myeloma

Saurav Chopra, MBBS, Timothy Dunham, Benjamin Darbro, MD PhD, Carol J Holman, MD PhD

Blood (2019) 134 (Supplement_1): 1880.

https://doi.org/10.1182/blood-2019-124411

Published: 2019

Journal Articles

Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome

Blood (2019) 134 (Supplement_1): 4621.

https://doi.org/10.1182/blood-2019-130922

Published: 2019

Journal Articles

Clustering Analysis of Myeloma Clone Phenotype Is Informative for Disease Heterogeneity and Prognosis at Relapse

Syeda Maheen Ahsan, Elisabet Nadal-Melsio, MD, Mark E Robinson, PhD, Richard Syzdlo, PhD, Eva Yebra-Fernandez, MD, Holger W Auner, MD PhD, Maria Atta, MD, Marco Bua, MD, Farah O'Boyle, PhD, Kikkeri Naresh, Jane Apperley, MB ChB MD, Anastasios Karadimitris, FRCPath, PhD, Aristeidis Chaidos, MD PhD

Blood (2018) 132 (Supplement 1): 4492.

https://doi.org/10.1182/blood-2018-99-117460

Published: 2018

Journal Articles

Comparison of Immunophenotypic Abnormalities in B-Lymphoblastic Leukemia (B-ALL) Minimal Residual Disease (MRD) of Adults and Children Utilizing the Children's Oncology Group (COG)-Validated Multiparameter Flow Cytometry (MFC)- MRD Approach: An Institutional Experience

Brooj Abro, MD, Cara Lunn Shirai, PhD, Anjum Hassan, MD, Yvette Kudlinski, Barbara Weddle, Friederike Kreisel, MD

Blood (2018) 132 (Supplement 1): 2661.

https://doi.org/10.1182/blood-2018-99-112317

Published: 2018

Journal Articles

Residual Allelic Burden Measured By Next-Generation Sequencing (NGS) at Remission Provides Limited Prognostic Value to Predict Relapse and Long-Term Outcome in Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Taehyung Kim, MSc, Joon Ho Moon, MD, Jae-Sook Ahn, MD PhD, Marc S. Tyndel, B. Eng, Seung-Shin Lee, MD, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Deok-Hwan Yang, MD, Je-Jung Lee, MD PhD, Seunghyun Choi, PhD, Ja-yeon Lee, MSc, Yoojin Lee, MDPhD, Sang Kyun Sohn, MDPhD, Hyeoung-Joon Kim, MD PhD, Zhaolei Zhang, PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2018) 132 (Supplement 1): 1391.

https://doi.org/10.1182/blood-2018-99-112906

Published: 2018

Journal Articles

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

Michael Hallek, Bruce D. Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillermo Dighiero, Hartmut Döhner, Peter Hillmen, Michael Keating, Emili Montserrat, Nicholas Chiorazzi, Stephan Stilgenbauer, Kanti R. Rai, John C. Byrd, Barbara Eichhorst, Susan O’Brien, Tadeusz Robak, John F. Seymour, Thomas J. Kipps

Blood (2018) 131 (25): 2745–2760.

https://doi.org/10.1182/blood-2017-09-806398

Published: 2018

Journal Articles

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Brent Wood, David Wu, Beryl Crossley, Yunfeng Dai, David Williamson, Charles Gawad, Michael J. Borowitz, Meenakshi Devidas, Kelly W. Maloney, Eric Larsen, Naomi Winick, Elizabeth Raetz, William L. Carroll, Stephen P. Hunger, Mignon L. Loh, Harlan Robins, Ilan Kirsch

Blood (2018) 131 (12): 1350–1359.

https://doi.org/10.1182/blood-2017-09-806521

Published: 2018

Includes: Supplemental data

Journal Articles

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Michael P. Chu, MD, Eva Baigorri, Jitra Kriangkum, PhD, Joanne D. Hewitt, NP, PhD, Andrew Belch, Christopher P. Venner, Irwindeep Sandhu, MDFRCPC, Linda M. Pilarski, PhD

Blood (2017) 130 (Supplement 1): 1928.

https://doi.org/10.1182/blood.V130.Suppl_1.1928.1928

Published: 2017

Journal Articles

Integrin alpha6-Deletion Induces Apoptosis and Src Signaling Changes in Acute Lymphoblastic Leukemia Cells

Eun Ji Gang, MD PhD, Hye Na Kim, Johanna Scott, PhD, Matthew J Oberley, MDPhD, Etan Orgel, MD MS, Steven D. Mittelman, MDPhD, Yao-Te Hsieh, PhD, Markus Muschen, MD, Deepa Bhojwani, MD, Daniel Braas, PhD, Thomas Graeber, PhD, Nora Heisterkamp, PhD, Yong-Mi Kim, MD MPH, PhD

Blood (2017) 130 (Supplement 1): 3878.

https://doi.org/10.1182/blood.V130.Suppl_1.3878.3878

Published: 2017

Journal Articles

Prohibitin Expression Level As a Companion Diagnostic Marker in Cytogenetically Normal Acute Myeloid Leukemia

Myung-Geun Shin, MD PhD, Moon James, BS, Jun Hyung Lee, MD MS, Hye-Ran Kim, PhD

Blood (2017) 130 (Supplement 1): 3933.

https://doi.org/10.1182/blood.V130.Suppl_1.3933.3933

Published: 2017

Journal Articles

An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data

Yu-Fen Wang, MS, Bor-Sheng Ko, MD, PhD, Chi-Cheng Li, MD, Jeng-Lin Li, BS, Pei-Fang Weng, BS, Huai-Hsuan Huang, MD, Hsin-An Hou, MD, PhD, Hwei-Fang Tien, MD, PhD, Chi-Chun Lee, PhD, Jih-Luh Tang, MD,PhD

Blood (2017) 130 (Supplement 1): 3980.

https://doi.org/10.1182/blood.V130.Suppl_1.3980.3980

Published: 2017

Journal Articles

Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders

Maria E. Arcila, Mustafa Syed, MS, Wayne Yu, B.S, Hannah Kim, B.S, JinYuan Yao, MD, Caleb Ho, MD, Kseniya Petrova-Drus, Mikhail Roshal, MDPhD, Jae H. Park, MD, Ola Landgren, MD PhD, Ahmet Dogan, MD PhD, Khedoudja Nafa, PhD

Blood (2017) 130 (Supplement 1): 4017.

https://doi.org/10.1182/blood.V130.Suppl_1.4017.4017

Published: 2017

Journal Articles

Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk

Marco Chiarini, MSc, Viviana Giustini, MSc, Francesco Buccisano, MD, Erika Borlenghi, MD, Mirko Farina, MD, Chiara Cattaneo, MD, Diego Bertoli, MSc, Federico Serana, MD PhD, Alessandro Montanelli, MD, Luisa Imberti, MD, Aldo M. Roccaro, Maria Ilaria Del Principe, Luca Maurillo, MD, PhD, Adriano Venditti, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 2697.

https://doi.org/10.1182/blood.V130.Suppl_1.2697.2697

Published: 2017

Journal Articles

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Udo Zur Stadt, PhD, Malik Alawi, M. Sc., Gabriele Escherich, MD, Martin A. Horstmann, MD

Blood (2017) 130 (Supplement 1): 2715.

https://doi.org/10.1182/blood.V130.Suppl_1.2715.2715

Published: 2017

Journal Articles

Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)

Carmen Fava, MD PhD, Simona Bernardi, PhD, Enrico Marco Gottardi, Dr., Filomena Daraio, PhD, Emilia Giugliano, Roberta Lorenzatti, Dr., Marta Varotto, Dr., Davide Barberio, Dr., Laura Galeotti, Francesco Ceccherini, Francesco Cordoni, Giovanna Rege-Carmbrin, Giuseppe Saglio, MD PhD, Domenico Russo, MD

Blood (2017) 130 (Supplement 1): 2867.

https://doi.org/10.1182/blood.V130.Suppl_1.2867.2867

Published: 2017

Journal Articles

Prognostic Significance of Minimal Residual Disease in Patients with Secondary Acute Myeloid Leukemia

Chi-Joan How, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Feng Gao, PhD, Rizwan Romee, MD

Blood (2017) 130 (Supplement 1): 5085.

https://doi.org/10.1182/blood.V130.Suppl_1.5085.5085

Published: 2017

Journal Articles

Anaplastic Large-Cell Lymphomas in Adults: The Cytogenetic and Molecular Genetic Characteristics, Treatment Results (a single institutional experience)

Liliya Gorenkova, PhD, Sergey K. Kravchenko, MD PhD, Alla M. Kovrigina, MD PhD, Vsevolod A. Misyurin, PhD, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5129.

https://doi.org/10.1182/blood.V130.Suppl_1.5129.5129

Published: 2017

NARROW

Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow

A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia

Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma

Utility of Flow Cytometry and Fluorescence in Situ Hybridization in Follow-up Monitoring of Multiple Myeloma

Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome

Clustering Analysis of Myeloma Clone Phenotype Is Informative for Disease Heterogeneity and Prognosis at Relapse

Comparison of Immunophenotypic Abnormalities in B-Lymphoblastic Leukemia (B-ALL) Minimal Residual Disease (MRD) of Adults and Children Utilizing the Children's Oncology Group (COG)-Validated Multiparameter Flow Cytometry (MFC)- MRD Approach: An Institutional Experience

Residual Allelic Burden Measured By Next-Generation Sequencing (NGS) at Remission Provides Limited Prognostic Value to Predict Relapse and Long-Term Outcome in Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Integrin alpha6-Deletion Induces Apoptosis and Src Signaling Changes in Acute Lymphoblastic Leukemia Cells

Prohibitin Expression Level As a Companion Diagnostic Marker in Cytogenetically Normal Acute Myeloid Leukemia

An Artificial Intelligence Approach for B Lymphoblastic Leukemia Minimal Residual Disease Detection and Clinical Prognosis Prediction Using Flow Cytometry Data

Next Generation Sequencing (NGS) Based IGH and TCR Clonality Assays Provide Excellent Specificity and Sensitivity for Routine Clonal Characterization and Monitoring of Lymphoproliferative Disorders

Identification of Relapse Risk Using a Multiparameter Flow Cytometry-Based Detection of Minimal Residual Disease in Adult Patients with Acute Myeloid Leukemia at ELN Intermediate-Risk

Rapid Capture NGS Identifies Genomic Rearrangements in BCP-ALL for MRD Diagnostics

Standardization of Two Dpcr Platforms for Detection of BCR/ABL1 - Minimal Residual Disease (MRD) in Ph+ Chronic Myeloid Leukemia (CML)

Prognostic Significance of Minimal Residual Disease in Patients with Secondary Acute Myeloid Leukemia

Anaplastic Large-Cell Lymphomas in Adults: The Cytogenetic and Molecular Genetic Characteristics, Treatment Results (a single institutional experience)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only